COM:ONCTERNAL
Oncternal Therapeutics
- Stock
Last Close
1.16
22/11 21:00
Market Cap
21.66M
Beta: -
Volume Today
22.02K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -42.11M - | -39.41M 6.41% | -18.70M 52.54% | -17.72M 5.23% | -30.44M 71.74% | -38.42M 26.21% | -34.19M 11.01% | -17.23M 49.62% | -31.33M 81.90% | -44.17M 40.97% | -39.48M 10.62% | |
depreciation and amortization | 384K - | 102K 73.44% | 43K 57.84% | 28K 34.88% | 47K 67.86% | 46K 2.13% | 150K - | 169K 12.67% | -75K 144.38% | |||
deferred income tax | -1.37M - | 8.80M 744.51% | -3.08M 135.00% | -8.16M 164.95% | -150K - | -169K 12.67% | ||||||
stock based compensation | 3.73M - | 4.43M 18.62% | 2.62M 40.83% | 2.96M 12.86% | 3.15M 6.56% | 2.20M 30.28% | 507K 76.92% | 1.56M 206.90% | 5.88M 277.57% | 7.43M 26.49% | 7.50M 0.93% | |
change in working capital | -4.75M - | -3.10M 34.60% | -1.03M 66.91% | 1.99M 293.96% | 3.62M 81.48% | -3.34M 192.31% | -2.51M 24.69% | -1.68M 33.35% | -1.30M 22.39% | -69K 94.69% | 1.27M 1,946.38% | |
accounts receivables | ||||||||||||
inventory | ||||||||||||
accounts payables | -899K - | -296K 67.07% | -130K 56.08% | 838K 744.62% | 1.38M 65.16% | 675K 51.23% | -4.76M 805.48% | 272K 105.71% | 816K 200% | 958K 17.40% | -1.77M 284.66% | |
other working capital | -3.85M - | -2.81M 27.01% | -897K 68.06% | 1.15M 228.65% | 2.23M 93.33% | -4.01M 279.83% | 2.25M 156.06% | -1.95M 186.57% | -2.12M 8.68% | -1.03M 51.47% | 3.04M 396.30% | |
other non cash items | 135K - | 422K 212.59% | 113K 73.22% | 132K 16.81% | 166K 25.76% | 166K 0% | 19.45M 11,615.66% | -151K 100.78% | 169K 211.92% | 179K 5.92% | -1.46M 915.08% | |
net cash provided by operating activities | -43.97M - | -28.76M 34.60% | -20.04M 30.33% | -20.78M 3.71% | -23.46M 12.91% | -39.35M 67.72% | -16.75M 57.44% | -17.50M 4.47% | -26.59M 51.98% | -36.70M 38.04% | -32.16M 12.37% | |
investments in property plant and equipment | -32K - | -5K 84.38% | -4K 20% | -90K 2,150% | -2K 97.78% | |||||||
acquisitions net | -10.69M - | -71.43M 568.23% | -37.65M 47.30% | -24.16M 35.82% | 16.14M - | |||||||
purchases of investments | -1.43M - | -41.91M 2,840.70% | -55.22M 31.77% | -35.40M 35.88% | -39.28M 10.96% | -44.16M 12.40% | -26.50M - | -64.35M 142.84% | ||||
sales maturities of investments | 9.27M - | 10.69M 15.32% | 71.43M 568.23% | 37.65M 47.30% | 24.16M 35.82% | 72.04M 198.18% | 65M - | |||||
other investing activites | 1.42M - | 10.69M 650.70% | 71.43M 568.23% | 37.65M 47.30% | 24.16M 35.82% | |||||||
net cash used for investing activites | 9.24M - | -31.22M 437.99% | 16.21M 151.93% | 2.15M 86.73% | -15.13M 803.21% | 27.88M 284.34% | 16.14M 42.13% | -26.50M - | 651K 102.46% | |||
debt repayment | -7K - | -2K 71.43% | -301K - | |||||||||
common stock issued | 63.95M - | 13.69M - | 45.65M 233.39% | 24.47M 46.39% | 1K 100.00% | 113.88M 11,387,500% | 617K 99.46% | 9.58M 1,453.00% | 1.22M 87.23% | |||
common stock repurchased | -3K - | -156K 5,100% | ||||||||||
dividends paid | ||||||||||||
other financing activites | 1.23M - | -617K 150.33% | -211K - | -156K 26.07% | -569K 264.74% | 14K 102.46% | 606K 4,228.57% | |||||
net cash used provided by financing activities | 1.22M - | 63.33M 5,095.24% | 13.48M - | 45.49M 237.45% | 23.91M 47.45% | 15K 99.94% | 114.18M 761,106.67% | 617K 99.46% | 9.58M 1,452.51% | 1.07M 88.85% | ||
effect of forex changes on cash | ||||||||||||
net change in cash | -33.52M - | 3.35M 110.00% | -3.82M 214.12% | -5.15M 34.57% | 6.91M 234.20% | 12.44M 80.16% | -594K 104.77% | 96.69M 16,377.10% | -25.97M 126.86% | -53.62M 106.46% | -30.45M 43.22% | |
cash at beginning of period | 48.04M - | 14.53M 69.76% | 17.88M 23.06% | 14.06M 21.39% | 8.91M 36.61% | 15.82M 77.51% | 20.64M 30.53% | 20.05M 2.88% | 116.74M 482.20% | 90.77M 22.25% | 37.14M 59.08% | |
cash at end of period | 14.53M - | 17.88M 23.06% | 14.06M 21.39% | 8.91M 36.61% | 15.82M 77.51% | 28.26M 78.67% | 20.05M 29.04% | 116.74M 482.20% | 90.77M 22.25% | 37.14M 59.08% | 6.70M 81.97% | |
operating cash flow | -43.97M - | -28.76M 34.60% | -20.04M 30.33% | -20.78M 3.71% | -23.46M 12.91% | -39.35M 67.72% | -16.75M 57.44% | -17.50M 4.47% | -26.59M 51.98% | -36.70M 38.04% | -32.16M 12.37% | |
capital expenditure | -32K - | -5K 84.38% | -4K 20% | -90K 2,150% | -2K 97.78% | |||||||
free cash flow | -44.00M - | -28.76M 34.63% | -20.04M 30.33% | -20.87M 4.14% | -23.46M 12.43% | -39.35M 67.70% | -16.75M 57.44% | -17.50M 4.47% | -26.59M 51.98% | -36.70M 38.04% | -32.16M 12.37% |
All numbers in USD (except ratios and percentages)